| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 988 | 0 | 0 | 576 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 3.659 | 4.490 | 3.587 | 3.513 | 1.166 | 2.727 | 2.712 |
| Total Expenses - EUR | - | - | 0 | 18.577 | 14.747 | 13.107 | 4.077 | 3.941 | 3.257 | 2.712 |
| Gross Profit/Loss - EUR | - | - | 0 | -14.919 | -10.258 | -9.520 | -564 | -2.775 | -530 | 0 |
| Net Profit/Loss - EUR | - | - | 0 | -14.929 | -10.258 | -9.520 | -582 | -2.810 | -530 | 0 |
| Employees | - | - | 0 | 2 | 2 | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Overexposure Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 53 | 28.391 | 23.352 | 19.322 | 15.907 | 12.081 | 9.317 | 6.553 |
| Current Assets | - | - | 35 | -3 | -1 | 2 | 576 | 0 | 0 | 0 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 576 | 0 | 0 | 0 |
| Cash | - | - | 35 | -3 | -1 | 2 | 0 | 0 | 0 | 0 |
| Shareholders Funds | - | - | 44 | -14.886 | -24.855 | -33.904 | -37.793 | -27.299 | -26.632 | -26.483 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 44 | 5.196 | 15.355 | 24.587 | 29.208 | 27.655 | 28.101 | 27.945 |
| Income in Advance | - | - | 0 | 38.078 | 32.851 | 28.641 | 25.069 | 11.726 | 7.848 | 5.093 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7420 - 7420" | |||||||||
| CAEN Financial Year |
7420
|
|||||||||
Comments - Overexposure Srl